SG11202011229RA - Methods and compositions for inhibiting a noxious insult - Google Patents

Methods and compositions for inhibiting a noxious insult

Info

Publication number
SG11202011229RA
SG11202011229RA SG11202011229RA SG11202011229RA SG11202011229RA SG 11202011229R A SG11202011229R A SG 11202011229RA SG 11202011229R A SG11202011229R A SG 11202011229RA SG 11202011229R A SG11202011229R A SG 11202011229RA SG 11202011229R A SG11202011229R A SG 11202011229RA
Authority
SG
Singapore
Prior art keywords
inhibiting
compositions
methods
noxious insult
insult
Prior art date
Application number
SG11202011229RA
Inventor
Oneel Patel
Joseph James Ischia
Damien Michael Bolton
Graham Sherard Baldwin
Arthur Shulkes
Original Assignee
Oneel Patel
Joseph James Ischia
Damien Michael Bolton
Graham Sherard Baldwin
Arthur Shulkes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018901826A external-priority patent/AU2018901826A0/en
Application filed by Oneel Patel, Joseph James Ischia, Damien Michael Bolton, Graham Sherard Baldwin, Arthur Shulkes filed Critical Oneel Patel
Publication of SG11202011229RA publication Critical patent/SG11202011229RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG11202011229RA 2018-05-25 2018-11-16 Methods and compositions for inhibiting a noxious insult SG11202011229RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018901826A AU2018901826A0 (en) 2018-05-25 Methods and compositions for inhibiting a noxious insult
PCT/AU2018/051226 WO2019222788A1 (en) 2018-05-25 2018-11-16 Methods and compositions for inhibiting a noxious insult

Publications (1)

Publication Number Publication Date
SG11202011229RA true SG11202011229RA (en) 2020-12-30

Family

ID=65365420

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202011229RA SG11202011229RA (en) 2018-05-25 2018-11-16 Methods and compositions for inhibiting a noxious insult

Country Status (9)

Country Link
US (2) US20210212932A1 (en)
EP (1) EP3801567A4 (en)
JP (1) JP7231717B2 (en)
KR (1) KR20210096558A (en)
CN (1) CN112912086A (en)
AU (1) AU2018260927B1 (en)
CA (1) CA3101482A1 (en)
SG (1) SG11202011229RA (en)
WO (1) WO2019222788A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05213764A (en) * 1992-02-03 1993-08-24 Terumo Corp Oxygen radical scavenger
US5955111A (en) * 1996-10-08 1999-09-21 Hartford Hospital Methods and compositions for inducing production of stress proteins
CA2346334A1 (en) * 1998-10-14 2000-04-20 Shionogi & Co., Ltd. Composition for treating or preventing ischemia reperfusion injury
JP2003503346A (en) * 1999-06-23 2003-01-28 ジンク セラピューテイクス カナダ インコーポレイテッド Zinc ionophore as an anti-apoptotic agent
EP2146711A4 (en) * 2007-04-12 2011-10-26 Univ Minnesota Ischemia/reperfusion protection compositions and methods of using

Also Published As

Publication number Publication date
JP2021526550A (en) 2021-10-07
EP3801567A1 (en) 2021-04-14
KR20210096558A (en) 2021-08-05
CA3101482A1 (en) 2019-11-28
CN112912086A (en) 2021-06-04
US20210212932A1 (en) 2021-07-15
WO2019222788A1 (en) 2019-11-28
US20240238195A1 (en) 2024-07-18
AU2018260927B1 (en) 2019-02-21
EP3801567A4 (en) 2022-04-20
JP7231717B2 (en) 2023-03-01

Similar Documents

Publication Publication Date Title
IL277079A (en) Cartyrin compositions and methods for use
SG11202103666PA (en) Methods and Compositions for Editing RNAs
IL280134A (en) Anti-cd112r compositions and methods
IL280508A (en) Geopolymer compositions and methods for making same
PT3626699T (en) Ssao inhibitor
EP3426732A4 (en) Polymeric agents and compositions for inhibiting corrosion
HK1251610A1 (en) Compositions and methods for inhibiting factor d
IL268684A (en) Compositions and methods for immunooncology
IL280123A (en) Compounds and methods for reducing atxn2 expression
IL275539A (en) Compositions and methods for inhibiting aldh2 expression
IL288024A (en) Methods and compositions for preventing type
IL279255A (en) Compositions and methods for evaluating genomic alterations
EP3737372C0 (en) Methods and compositions utilizing rrx-001 for radioprotection
IL274524A (en) Compositions and methods for aquaculturing
PL3567061T3 (en) Polypropylene pipe composition
IL291202A (en) Compositions and methods for characterizing a microbiome
GB201818084D0 (en) Compositions and methods
IL280330A (en) Compositions and related methods for agriculture
IL290325A (en) Biopharmacuetical compositions and related methods
IL284327A (en) Compositions and methods for inhibiting hmgb1 expression
GB201819987D0 (en) Methods and compositions
GB201817444D0 (en) Methods and compositions
GB201819045D0 (en) Csf1r binding agents
SG11202011229RA (en) Methods and compositions for inhibiting a noxious insult
IL287316A (en) Compounds and compositions